Cite
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
MLA
Hannah Preßler, et al. “IA-PACS-CFS: A Double-Blinded, Randomized, Sham-Controlled, Exploratory Trial of Immunoadsorption in Patients with Chronic Fatigue Syndrome (CFS) Including Patients with Post-Acute COVID-19 CFS (PACS-CFS).” Trials, vol. 25, no. 1, Mar. 2024, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13063-024-07982-5.
APA
Hannah Preßler, Marie-Luise Machule, Friederike Ufer, Isabel Bünger, Lucie Yuanting Li, Emilie Buchholz, Claudia Werner, Esther Beraha, Frank Wagner, Matthes Metz, Susen Burock, Lisa Bruckert, Christiana Franke, Nicola Wilck, Anne Krüger, Alexander Reshetnik, Kai-Uwe Eckardt, Matthias Endres, & Harald Prüss. (2024). IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS). Trials, 25(1), 1–16. https://doi.org/10.1186/s13063-024-07982-5
Chicago
Hannah Preßler, Marie-Luise Machule, Friederike Ufer, Isabel Bünger, Lucie Yuanting Li, Emilie Buchholz, Claudia Werner, et al. 2024. “IA-PACS-CFS: A Double-Blinded, Randomized, Sham-Controlled, Exploratory Trial of Immunoadsorption in Patients with Chronic Fatigue Syndrome (CFS) Including Patients with Post-Acute COVID-19 CFS (PACS-CFS).” Trials 25 (1): 1–16. doi:10.1186/s13063-024-07982-5.